Most Read Articles
Pearl Toh, 5 days ago
Every-two-month injections of the long-acting cabotegravir + rilpivirine were noninferior to once-monthly injections for virologic suppression at 48 weeks in people living with HIV*, according to the ATLAS-2M** study presented at CROI 2020 — thus providing a potential option with more convenient dosing.
5 days ago
Treatment with direct oral anticoagulant (DOAC) plus P2Y12 inhibitor (dual therapy) in adults with nonvalvular atrial fibrillation (AF) after percutaneous coronary intervention (PCI) reduces bleeding risk compared with vitamin K antagonist plus aspirin and P2Y12 inhibitor (triple therapy), suggest a study.
Jairia Dela Cruz, 6 days ago
“Wash your hands” may be old advice but, when done right, is crucial in preventing the spread of COVID-19 or any viral infections, as epidemiologists say. Aside from hand hygiene, other forms of physical barriers that effectively halt transmission include wearing masks and social distancing.
24 Mar 2020
COVID-19 is a novel disease, with no existing immunity. The virus can be transmitted from person to person, quickly and exponentially. Here’s what we can do to slow down the spread, if not contain the outbreak.

Product Highlight - FontActiv

29 Nov 2018

FontActiv - PT. Konimex Indonesia

Fulfill Your Nutrition Necessity

  • Nutrisi komplit, High Protein & High Calories
  • Kandungan protein yang tinggi dari Milk Protein, membantu membangun pertumbuhan massa otot
  • Profil lemak dari 100% Canola Oil yang seimbang akan mono dan poly-unsaturated fats
  • Mengandung mineral dan vitamin yang komplit
  • Delicious Flavor
  • FontActiv HP / HC: 300 kcal/200 ml
  • FontActiv Two: 400 kcal/ 200 ml

Further information is available in MIMS section 13b.

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Indonesia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 5 days ago
Every-two-month injections of the long-acting cabotegravir + rilpivirine were noninferior to once-monthly injections for virologic suppression at 48 weeks in people living with HIV*, according to the ATLAS-2M** study presented at CROI 2020 — thus providing a potential option with more convenient dosing.
5 days ago
Treatment with direct oral anticoagulant (DOAC) plus P2Y12 inhibitor (dual therapy) in adults with nonvalvular atrial fibrillation (AF) after percutaneous coronary intervention (PCI) reduces bleeding risk compared with vitamin K antagonist plus aspirin and P2Y12 inhibitor (triple therapy), suggest a study.
Jairia Dela Cruz, 6 days ago
“Wash your hands” may be old advice but, when done right, is crucial in preventing the spread of COVID-19 or any viral infections, as epidemiologists say. Aside from hand hygiene, other forms of physical barriers that effectively halt transmission include wearing masks and social distancing.
24 Mar 2020
COVID-19 is a novel disease, with no existing immunity. The virus can be transmitted from person to person, quickly and exponentially. Here’s what we can do to slow down the spread, if not contain the outbreak.